The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Cancer cachexia is the progressive loss of skeletal muscle mass and adipose tissue, negative nitrogen balance, anorexia, fatigue, inflammation, and activation of lipolysis and proteolysis systems. Cancer patients with cachexia benefit less from anti-neoplastic therapies and show increased mortality...
Gespeichert in:
| Veröffentlicht in: | Journal of visualized experiments H. 117 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
MyJove Corporation
30.11.2016
|
| Schlagworte: | |
| ISSN: | 1940-087X, 1940-087X |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Cancer cachexia is the progressive loss of skeletal muscle mass and adipose tissue, negative nitrogen balance, anorexia, fatigue, inflammation, and activation of lipolysis and proteolysis systems. Cancer patients with cachexia benefit less from anti-neoplastic therapies and show increased mortality
. Several animal models have been established in order to investigate the molecular causes responsible for body and muscle wasting as a result of tumor growth. Here, we describe methodologies pertaining to a well-characterized model of cancer cachexia: mice bearing the C26 carcinoma
. Although this model is heavily used in cachexia research, different approaches make reproducibility a potential issue. The growth of the C26 tumor causes a marked and progressive loss of body and skeletal muscle mass, accompanied by reduced muscle cross-sectional area and muscle strength
. Adipose tissue is also lost. Wasting is coincident with elevated circulating levels of pro-inflammatory cytokines, particularly Interleukin-6 (IL-6)
, which is directly, although not entirely, responsible for C26 cachexia. It is well-accepted that a primary mechanism by which the C26 tumor induces muscle tissue depletion is the activation of skeletal muscle proteolytic systems. Thus, expression of muscle-specific ubiquitin ligases, such as atrogin-1/MAFbx and MuRF-1, represent an accepted method for the evaluation of the ongoing muscle catabolism
. Here, we present how to execute this model in a reproducible manner and how to excise several tissues and organs (the liver, spleen, and heart), as well as fat and skeletal muscles (the gastrocnemius, tibialis anterior, and quadriceps). We also provide useful protocols that describe how to perform muscle freezing, sectioning, and fiber size quantification. |
|---|---|
| AbstractList | Cancer cachexia is the progressive loss of skeletal muscle mass and adipose tissue, negative nitrogen balance, anorexia, fatigue, inflammation, and activation of lipolysis and proteolysis systems. Cancer patients with cachexia benefit less from anti-neoplastic therapies and show increased mortality1. Several animal models have been established in order to investigate the molecular causes responsible for body and muscle wasting as a result of tumor growth. Here, we describe methodologies pertaining to a well-characterized model of cancer cachexia: mice bearing the C26 carcinoma2-4. Although this model is heavily used in cachexia research, different approaches make reproducibility a potential issue. The growth of the C26 tumor causes a marked and progressive loss of body and skeletal muscle mass, accompanied by reduced muscle cross-sectional area and muscle strength3-5. Adipose tissue is also lost. Wasting is coincident with elevated circulating levels of pro-inflammatory cytokines, particularly Interleukin-6 (IL-6)3, which is directly, although not entirely, responsible for C26 cachexia. It is well-accepted that a primary mechanism by which the C26 tumor induces muscle tissue depletion is the activation of skeletal muscle proteolytic systems. Thus, expression of muscle-specific ubiquitin ligases, such as atrogin-1/MAFbx and MuRF-1, represent an accepted method for the evaluation of the ongoing muscle catabolism2. Here, we present how to execute this model in a reproducible manner and how to excise several tissues and organs (the liver, spleen, and heart), as well as fat and skeletal muscles (the gastrocnemius, tibialis anterior, and quadriceps). We also provide useful protocols that describe how to perform muscle freezing, sectioning, and fiber size quantification.Cancer cachexia is the progressive loss of skeletal muscle mass and adipose tissue, negative nitrogen balance, anorexia, fatigue, inflammation, and activation of lipolysis and proteolysis systems. Cancer patients with cachexia benefit less from anti-neoplastic therapies and show increased mortality1. Several animal models have been established in order to investigate the molecular causes responsible for body and muscle wasting as a result of tumor growth. Here, we describe methodologies pertaining to a well-characterized model of cancer cachexia: mice bearing the C26 carcinoma2-4. Although this model is heavily used in cachexia research, different approaches make reproducibility a potential issue. The growth of the C26 tumor causes a marked and progressive loss of body and skeletal muscle mass, accompanied by reduced muscle cross-sectional area and muscle strength3-5. Adipose tissue is also lost. Wasting is coincident with elevated circulating levels of pro-inflammatory cytokines, particularly Interleukin-6 (IL-6)3, which is directly, although not entirely, responsible for C26 cachexia. It is well-accepted that a primary mechanism by which the C26 tumor induces muscle tissue depletion is the activation of skeletal muscle proteolytic systems. Thus, expression of muscle-specific ubiquitin ligases, such as atrogin-1/MAFbx and MuRF-1, represent an accepted method for the evaluation of the ongoing muscle catabolism2. Here, we present how to execute this model in a reproducible manner and how to excise several tissues and organs (the liver, spleen, and heart), as well as fat and skeletal muscles (the gastrocnemius, tibialis anterior, and quadriceps). We also provide useful protocols that describe how to perform muscle freezing, sectioning, and fiber size quantification. Cancer cachexia is the progressive loss of skeletal muscle mass and adipose tissue, negative nitrogen balance, anorexia, fatigue, inflammation, and activation of lipolysis and proteolysis systems. Cancer patients with cachexia benefit less from anti-neoplastic therapies and show increased mortality1. Several animal models have been established in order to investigate the molecular causes responsible for body and muscle wasting as a result of tumor growth. Here, we describe methodologies pertaining to a well-characterized model of cancer cachexia: mice bearing the C26 carcinoma2-4. Although this model is heavily used in cachexia research, different approaches make reproducibility a potential issue. The growth of the C26 tumor causes a marked and progressive loss of body and skeletal muscle mass, accompanied by reduced muscle cross-sectional area and muscle strength3-5. Adipose tissue is also lost. Wasting is coincident with elevated circulating levels of pro-inflammatory cytokines, particularly Interleukin-6 (IL-6)3, which is directly, although not entirely, responsible for C26 cachexia. It is well-accepted that a primary mechanism by which the C26 tumor induces muscle tissue depletion is the activation of skeletal muscle proteolytic systems. Thus, expression of muscle-specific ubiquitin ligases, such as atrogin-1/MAFbx and MuRF-1, represent an accepted method for the evaluation of the ongoing muscle catabolism2. Here, we present how to execute this model in a reproducible manner and how to excise several tissues and organs (the liver, spleen, and heart), as well as fat and skeletal muscles (the gastrocnemius, tibialis anterior, and quadriceps). We also provide useful protocols that describe how to perform muscle freezing, sectioning, and fiber size quantification. Cancer cachexia is the progressive loss of skeletal muscle mass and adipose tissue, negative nitrogen balance, anorexia, fatigue, inflammation, and activation of lipolysis and proteolysis systems. Cancer patients with cachexia benefit less from anti-neoplastic therapies and show increased mortality . Several animal models have been established in order to investigate the molecular causes responsible for body and muscle wasting as a result of tumor growth. Here, we describe methodologies pertaining to a well-characterized model of cancer cachexia: mice bearing the C26 carcinoma . Although this model is heavily used in cachexia research, different approaches make reproducibility a potential issue. The growth of the C26 tumor causes a marked and progressive loss of body and skeletal muscle mass, accompanied by reduced muscle cross-sectional area and muscle strength . Adipose tissue is also lost. Wasting is coincident with elevated circulating levels of pro-inflammatory cytokines, particularly Interleukin-6 (IL-6) , which is directly, although not entirely, responsible for C26 cachexia. It is well-accepted that a primary mechanism by which the C26 tumor induces muscle tissue depletion is the activation of skeletal muscle proteolytic systems. Thus, expression of muscle-specific ubiquitin ligases, such as atrogin-1/MAFbx and MuRF-1, represent an accepted method for the evaluation of the ongoing muscle catabolism . Here, we present how to execute this model in a reproducible manner and how to excise several tissues and organs (the liver, spleen, and heart), as well as fat and skeletal muscles (the gastrocnemius, tibialis anterior, and quadriceps). We also provide useful protocols that describe how to perform muscle freezing, sectioning, and fiber size quantification. |
| Author | Bonetto, Andrea Barreto, Rafael Zimmers, Teresa A. Rupert, Joseph E. |
| AuthorAffiliation | 1 Department of Surgery, Simon Cancer Center and IUPUI Center for Cachexia Research, Innovation and Therapy, Indiana University School of Medicine |
| AuthorAffiliation_xml | – name: 1 Department of Surgery, Simon Cancer Center and IUPUI Center for Cachexia Research, Innovation and Therapy, Indiana University School of Medicine |
| Author_xml | – sequence: 1 givenname: Andrea surname: Bonetto fullname: Bonetto, Andrea – sequence: 2 givenname: Joseph E. surname: Rupert fullname: Rupert, Joseph E. – sequence: 3 givenname: Rafael surname: Barreto fullname: Barreto, Rafael – sequence: 4 givenname: Teresa A. surname: Zimmers fullname: Zimmers, Teresa A. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27929469$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUtr3TAQhUVJaZ5_IWgTKBS3etmyNoFw6QtSuuhN6U6MdUe5CraUSHZp_n2VJg1pNl3NwHxzOGdmn-zEFJGQI87eSm34u1b1Rr4ge9wo1rBe_9h50u-S_VKuGOsEa_tXZFdoI4zqzB75vt4iXaUxxUZ0dAXZhZgmoOtlSrkZEHKIl_RLWgpSKBRqu8GR-pTpXDe_zcvmliZfN6PDXIvb4q8Ah-Slh7Hg0UM9IBcf3q9Xn5rzrx8_r87OG6d6PjeD0kxIMQyGOSF4z7xTCjXzrZda6wE2bgDBHTDlkCsJbaeM79Br4E6yQR6Q03vd62WYcOMwzhlGe53DBPnWJgj230kMW3uZftpWiE5KUQVePwjkdLNgme0UisNxhIg1tBWilaJaFOa_KO-V7nupparo8VNbj37-3r0CJ_eAy6mUjP4R4cze_dP--Wfl3jzjXJhhDukuTRif0b8BVUOemw |
| CitedBy_id | crossref_primary_10_3390_cancers16132364 crossref_primary_10_1186_s13765_019_0417_5 crossref_primary_10_1002_jcsm_13329 crossref_primary_10_3390_cancers12123787 crossref_primary_10_3390_cancers12082312 crossref_primary_10_1242_dmm_043166 crossref_primary_10_1152_ajpregu_00035_2025 crossref_primary_10_1155_2018_6419805 crossref_primary_10_1242_dmm_032383 crossref_primary_10_1371_journal_pone_0283806 crossref_primary_10_1152_japplphysiol_00173_2024 crossref_primary_10_3389_fmolb_2021_812681 crossref_primary_10_1002_jcsm_12627 crossref_primary_10_1038_s41467_024_48971_1 crossref_primary_10_3389_fcell_2022_960341 crossref_primary_10_3390_nu14112306 crossref_primary_10_1152_japplphysiol_00196_2023 crossref_primary_10_1016_j_canlet_2021_06_030 crossref_primary_10_3389_fcell_2021_690452 crossref_primary_10_1002_jcsm_12303 crossref_primary_10_1088_1758_5090_ac6c4b crossref_primary_10_1002_jcsm_12745 crossref_primary_10_1016_j_bone_2019_04_012 crossref_primary_10_1038_s41401_019_0275_z crossref_primary_10_1152_ajpcell_00327_2024 crossref_primary_10_1007_s11010_020_03882_9 crossref_primary_10_1038_s41598_018_30569_5 crossref_primary_10_3389_fphar_2024_1455805 crossref_primary_10_1113_JP283569 crossref_primary_10_1152_ajpregu_00028_2019 crossref_primary_10_1152_ajpcell_00374_2025 crossref_primary_10_3390_cancers12113221 crossref_primary_10_1038_s41598_020_60396_6 crossref_primary_10_3390_nu15010102 crossref_primary_10_1152_ajpcell_00317_2024 crossref_primary_10_3389_fcell_2020_00033 crossref_primary_10_3390_cancers13246389 |
| ContentType | Journal Article |
| Copyright | Copyright © 2016, Journal of Visualized Experiments 2016 |
| Copyright_xml | – notice: Copyright © 2016, Journal of Visualized Experiments 2016 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
| DOI | 10.3791/54893 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE - Academic AGRICOLA MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1940-087X |
| ExternalDocumentID | PMC5226332 27929469 10_3791_54893 |
| Genre | Video-Audio Media Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: R21 CA190028 – fundername: NCI NIH HHS grantid: R01 CA122596 – fundername: NCI NIH HHS grantid: R01 CA194593 |
| GroupedDBID | --- 223 29L 53G 5GY AAHBH AAHTB AAYXX ABPEJ ACGFO ADBBV AKRSQ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION CS3 DIK E3Z GX1 HYE OK1 RPM SJN CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
| ID | FETCH-LOGICAL-c481t-b470232bb90c22180fc44e70f5f3777badcba21ca04ce143a5649f6ef7a1c30b3 |
| IEDL.DBID | 223 |
| ISICitedReferencesCount | 93 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000415734600014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1940-087X |
| IngestDate | Tue Sep 30 16:58:32 EDT 2025 Fri Jul 11 06:50:30 EDT 2025 Thu Jul 10 19:58:25 EDT 2025 Thu Jan 02 23:10:16 EST 2025 Sat Nov 29 08:14:10 EST 2025 Tue Nov 18 22:17:14 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 117 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c481t-b470232bb90c22180fc44e70f5f3777badcba21ca04ce143a5649f6ef7a1c30b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Correspondence to: Teresa A. Zimmers at zimmerst@iu.edu |
| OpenAccessLink | https://www.jove.com/pdf/54893/the-colon-26-carcinoma-tumor-bearing-mouse-as-model-for-study-cancer |
| PMID | 27929469 |
| PQID | 1847883734 |
| PQPubID | 23479 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5226332 proquest_miscellaneous_2253223229 proquest_miscellaneous_1847883734 pubmed_primary_27929469 crossref_primary_10_3791_54893 crossref_citationtrail_10_3791_54893 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-11-30 |
| PublicationDateYYYYMMDD | 2016-11-30 |
| PublicationDate_xml | – month: 11 year: 2016 text: 2016-11-30 day: 30 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of visualized experiments |
| PublicationTitleAlternate | J Vis Exp |
| PublicationYear | 2016 |
| Publisher | MyJove Corporation |
| Publisher_xml | – name: MyJove Corporation |
| References | 22564195 - Int J Exp Pathol. 2012 Jun;93(3):157-71 21519918 - Ann Surg Oncol. 2012 Apr;19(4):1350-6 25539728 - BMC Cancer. 2014 Dec 24;14:997 21163868 - Cancer Res. 2011 Mar 1;71(5):1710-20 15286803 - J Clin Invest. 2004 Aug;114(3):370-8 22476919 - J Cachexia Sarcopenia Muscle. 2012 Sep;3(3):199-211 20615237 - BMC Cancer. 2010 Jul 08;10:363 24489962 - PLoS One. 2014 Jan 29;9(1):e87776 19508174 - Curr Cancer Drug Targets. 2009 Aug;9(5):608-16 16614058 - Am J Physiol Regul Integr Comp Physiol. 2006 Sep;291(3):R674-83 10403450 - Lab Anim Sci. 1999 Jun;49(3):319-23 10444430 - Am J Physiol. 1999 Aug;277(2 Pt 1):E332-41 22669242 - Am J Physiol Endocrinol Metab. 2012 Aug 1;303(3):E410-21 23861230 - Muscle Nerve. 2013 Sep;48(3):387-92 21296615 - Lancet Oncol. 2011 May;12(5):489-95 26092726 - J Biol Chem. 2015 Aug 7;290(32):19976-86 21048967 - PLoS One. 2010 Oct 27;5(10):e13604 22296872 - Clin Nutr. 2012 Aug;31(4):499-505 22476918 - J Cachexia Sarcopenia Muscle. 2012 Jun;3(2):111-6 19246111 - Int J Cardiol. 2009 Apr 17;133(3):388-93 16140458 - Cancer Lett. 2006 Jul 28;239(1):78-83 16286249 - Cancer Cell. 2005 Nov;8(5):421-32 19860537 - Expert Opin Emerg Drugs. 2009 Dec;14(4):619-32 18039237 - Dev Med Child Neurol. 2007 Dec;49(12):907-14 26331011 - Bonekey Rep. 2015 Aug 19;4:732 21799891 - PLoS One. 2011;6(7):e22538 18541999 - Curr Opin Clin Nutr Metab Care. 2008 Jul;11(4):400-7 7628876 - Int J Cancer. 1995 Jul 28;62(3):332-6 11547537 - Biol Res Nurs. 2001 Jan;2(3):155-66 20036643 - Biochem Biophys Res Commun. 2010 Jan 15;391(3):1548-54 25457061 - Cancer Biol Ther. 2015;16(6):886-97 |
| References_xml | – reference: 26331011 - Bonekey Rep. 2015 Aug 19;4:732 – reference: 21799891 - PLoS One. 2011;6(7):e22538 – reference: 21163868 - Cancer Res. 2011 Mar 1;71(5):1710-20 – reference: 18039237 - Dev Med Child Neurol. 2007 Dec;49(12):907-14 – reference: 25539728 - BMC Cancer. 2014 Dec 24;14:997 – reference: 18541999 - Curr Opin Clin Nutr Metab Care. 2008 Jul;11(4):400-7 – reference: 16140458 - Cancer Lett. 2006 Jul 28;239(1):78-83 – reference: 19508174 - Curr Cancer Drug Targets. 2009 Aug;9(5):608-16 – reference: 22476919 - J Cachexia Sarcopenia Muscle. 2012 Sep;3(3):199-211 – reference: 22564195 - Int J Exp Pathol. 2012 Jun;93(3):157-71 – reference: 23861230 - Muscle Nerve. 2013 Sep;48(3):387-92 – reference: 21296615 - Lancet Oncol. 2011 May;12(5):489-95 – reference: 20615237 - BMC Cancer. 2010 Jul 08;10:363 – reference: 21048967 - PLoS One. 2010 Oct 27;5(10):e13604 – reference: 25457061 - Cancer Biol Ther. 2015;16(6):886-97 – reference: 19860537 - Expert Opin Emerg Drugs. 2009 Dec;14(4):619-32 – reference: 22476918 - J Cachexia Sarcopenia Muscle. 2012 Jun;3(2):111-6 – reference: 16614058 - Am J Physiol Regul Integr Comp Physiol. 2006 Sep;291(3):R674-83 – reference: 24489962 - PLoS One. 2014 Jan 29;9(1):e87776 – reference: 22669242 - Am J Physiol Endocrinol Metab. 2012 Aug 1;303(3):E410-21 – reference: 15286803 - J Clin Invest. 2004 Aug;114(3):370-8 – reference: 10403450 - Lab Anim Sci. 1999 Jun;49(3):319-23 – reference: 20036643 - Biochem Biophys Res Commun. 2010 Jan 15;391(3):1548-54 – reference: 21519918 - Ann Surg Oncol. 2012 Apr;19(4):1350-6 – reference: 10444430 - Am J Physiol. 1999 Aug;277(2 Pt 1):E332-41 – reference: 16286249 - Cancer Cell. 2005 Nov;8(5):421-32 – reference: 22296872 - Clin Nutr. 2012 Aug;31(4):499-505 – reference: 19246111 - Int J Cardiol. 2009 Apr 17;133(3):388-93 – reference: 26092726 - J Biol Chem. 2015 Aug 7;290(32):19976-86 – reference: 7628876 - Int J Cancer. 1995 Jul 28;62(3):332-6 – reference: 11547537 - Biol Res Nurs. 2001 Jan;2(3):155-66 |
| SSID | ssj0062058 |
| Score | 2.4261746 |
| Snippet | Cancer cachexia is the progressive loss of skeletal muscle mass and adipose tissue, negative nitrogen balance, anorexia, fatigue, inflammation, and activation... |
| SourceID | pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| SubjectTerms | adipose tissue animal models Animals anorexia cachexia Cachexia - etiology Cancer Research carcinoma Cell Line, Tumor Colonic Neoplasms Disease Models, Animal freezing heart Humans inflammation Interleukin-6 lipolysis liver Mice Muscle, Skeletal muscles Muscular Atrophy - etiology nitrogen balance patients proteolysis Reproducibility of Results skeletal muscle spleen ubiquitin-protein ligase |
| Title | The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/27929469 https://www.proquest.com/docview/1847883734 https://www.proquest.com/docview/2253223229 https://pubmed.ncbi.nlm.nih.gov/PMC5226332 |
| WOSCitedRecordID | wos000415734600014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVDIW databaseName: Journal of Visualized Experiments : JoVE customDbUrl: eissn: 1940-087X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062058 issn: 1940-087X databaseCode: 223 dateStart: 0 isFulltext: true titleUrlDefault: https://www.jove.com/journal providerName: Journal of Visualized Experiments |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dS8MwED9kqAji98f8jLDXYNJkSfsoQ_FBxQeVvZUkbXCwdTKnuP_eS7tNNxWhtJReaLg77u5Hjt8BNLJAG-VMQr3jjmI-djT23NNYKIUVc2SZKynzb_TdXdxuJ_cLcPrrCb7QCT9vBnoUjLEiZqFlK_qKtCpi5fxNxOGhJ0u3l2F1ZtVsrvlRQM73QX5LLFfr_25pA9bGNSO5qIy8CQt5sQVL1RTJ0TY8oalJC18KGinSCsOBin7PkIe3Xn9ALboypidyixA_J-aVGBLmn3UJVqsEqz8SOglHpO9xJTrAAB9ox4-O2YHHq8uH1jUdj0ugTsZ8SK3UmIAjaxPmIszczDspc8180wuttTWZsyZCwzDpciyTTFPJxKvca8OdYFbsQq3oF_k-EOWk4yLT2jQRnklpFecIwU3CM-NMxurQmCg2dWMu8TDSopsipggqSksV1eFkKvZSkWfMC5xNrJKiW4ezClPkqI8UgSeCc6GF_FsGQxGGI7ySOuxVlpz-JvAiJgj966BnbDwVCLTas1-KznNJrx0qUiGig_82fwgrWD2pigfyCGrDwVt-DIvufdh5HZyUnop33Y4_AfyE4Yk |
| linkProvider | Journal of Visualized Experiments |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Colon-26+Carcinoma+Tumor-bearing+Mouse+as+a+Model+for+the+Study+of+Cancer+Cachexia&rft.jtitle=Journal+of+visualized+experiments&rft.au=Bonetto%2C+Andrea&rft.au=Rupert%2C+Joseph+E.&rft.au=Barreto%2C+Rafael&rft.au=Zimmers%2C+Teresa+A.&rft.date=2016-11-30&rft.pub=MyJove+Corporation&rft.eissn=1940-087X&rft.issue=117&rft_id=info:doi/10.3791%2F54893&rft_id=info%3Apmid%2F27929469&rft.externalDocID=PMC5226332 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1940-087X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1940-087X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1940-087X&client=summon |